Plasma lipid levels and colorectal adenoma risk

Cancer Causes and Control

Volumn 26, Issue 4, 2015, Pages 635-643

  Coppola, John Anthony ^a   Shrubsole, Martha J ^b,c,e   Cai, Qiuyin ^b,e   Smalley, Walter E ^b   Dai, Qi ^b,e   Ness, Reid M ^b   Fazio, Sergio ^d   Zheng, Wei ^b,c,e   Murff, Harvey J ^b,c,e  

^a FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Colorectal; Hypolipidemic agents; Lipoproteins; Neoplasms

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COLORECTAL ADENOMA; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR RISK; TUMOR VOLUME; ADENOMA; BLOOD; COLORECTAL NEOPLASMS; MIDDLE AGED; ODDS RATIO; STATISTICAL MODEL; TENNESSEE;

ADENOMA; AGED; CHOLESTEROL, HDL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; TENNESSEE;

EID: 84925493970     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-015-0555-y     Document Type: Article

References (33)

1. Wu L, Yu C, Jiang H, Tang J, Huang HL, Gao J, Zhang X (2013) Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies. Diabetes Technol Ther 15(5):419–427. doi:10.1089/dia.2012.0263
2. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D (2012) Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35(11):2402–2411. doi:10.2337/dc12-0336
3. Nikolic D, Katsiki N, Montalto G, Isenovic ER, Mikhailidis DP, Rizzo M (2013) Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients 5(3):928–948. doi:10.3390/nu5030928
4. Bird CL, Ingles SA, Frankl HD, Lee ER, Longnecker MP, Haile RW (1996) Serum lipids and adenomas of the left colon and rectum. Cancer Epidemiol Biomarkers Prev 5(8):607–612
5. Kim BC, Shin A, Hong CW, Sohn DK, Han KS, Ryu KH, Park BJ, Nam JH, Park JW, Chang HJ, Choi HS, Kim J, Oh JH (2012) Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 23(5):727–735. doi:10.1007/s10552-012-9942-9
6. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, Frohlich J, Ayyobi A, Overvad K, Toft-Petersen AP, Tjonneland A, Hansen L, Boutron-Ruault MC, Clavel-Chapelon F, Cottet V, Palli D, Tagliabue G, Panico S, Tumino R, Vineis P, Kaaks R, Teucher B, Boeing H, Drogan D, Trichopoulou A, Lagiou P, Dilis V, Peeters PH, Siersema PD, Rodriguez L, Gonzalez CA, Molina-Montes E, Dorronsoro M, Tormo MJ, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Tsilidis KK, Crowe FL, Chajes V, Fedirko V, Rinaldi S, Norat T, Riboli E (2011) Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into cancer and nutrition. Gut 60(8):1094–1102. doi:10.1136/gut.2010.225011
7. Yang MH, Rampal S, Sung J, Choi YH, Son HJ, Lee JH, Kim YH, Chang DK, Rhee PL, Kim JJ, Rhee JC, Chun HK, Guallar E, Cho J (2013) The association of serum lipids with colorectal adenomas. Am J Gastroenterol 108(5):833–841. doi:10.1038/ajg.2013.64
8. Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, Kim JJ, Rhee JC, Choi YH (2007) Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 16(8):1543–1546. doi:10.1158/1055-9965.EPI-07-0199
9. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107(1):28–36. doi:10.1002/cncr.21950
10. Park SK, Joo JS, Kim DH, Kim YE, Kang D, Yoo KY (2000) Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case–control study in Korea. J Korean Med Sci 15(6):690–695
11. Bayerdorffer E, Mannes GA, Richter WO, Ochsenkuhn T, Seeholzer G, Kopcke W, Wiebecke B, Paumgartner G (1993) Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann Intern Med 118(7):481–487
12. Lee GE, Park HS, Yun KE, Jun SH, Kim HK, Cho SI, Kim JH (2008) Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring) 16(6):1434–1439. doi:10.1038/oby.2008.216
13. Otani T, Iwasaki M, Ikeda S, Kozu T, Saito H, Mutoh M, Wakabayashi K, Tsugane S (2006) Serum triglycerides and colorectal adenoma in a case–control study among cancer screening examinees (Japan). Cancer Causes Control 17(10):1245–1252. doi:10.1007/s10552-006-0065-z
14. Liu CS, Hsu HS, Li CI, Jan CI, Li TC, Lin WY, Lin T, Chen YC, Lee CC, Lin CC (2010) Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol 10:51. doi:10.1186/1471-230X-10-51
15. Gaard M, Tretli S, Urdal P (1997) Blood lipid and lipoprotein levels and the risk of cancer of the colon and rectum. A prospective study of 62,173 Norwegian men and women. Scand J Gastroenterol 32(2):162–168
16. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G (2005) Statins and the risk of colorectal cancer. N Engl J Med 352(21):2184–2192. doi:10.1056/NEJMoa043792
17. McKeown-Eyssen G (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 3(8):687–695
18. Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86(3):s836–s842
19. Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169(5):1505–1522. doi:10.2353/ajpath.2006.051090
20. Kim YJ, Kim EH, Hahm KB (2012) Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities. J Gastroenterol Hepatol 27(6):1004–1010. doi:10.1111/j.1440-1746.2012.07108.x
21. Barrasa JI, Olmo N, Lizarbe MA, Turnay J (2013) Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 27(2):964–977. doi:10.1016/j.tiv.2012.12.020
22. Schwartz CC, Halloran LG, Vlahcevic ZR, Gregory DH, Swell L (1978) Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. Science 200(4337):62–64
23. Robins SJ, Fasulo JM (1997) High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. J Clin Invest 99(3):380–384. doi:10.1172/JCI119170
24. Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W (2008) Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 167(9):1050–1058. doi:10.1093/aje/kwm400
25. Shrubsole MJ, Cai Q, Wen W, Milne G, Smalley WE, Chen Z, Ness RM, Zheng W (2012) Urinary prostaglandin E2 metabolite and risk for colorectal adenoma. Cancer Prev Res (Phila) 5(2):336–342. doi:10.1158/1940-6207.CAPR-11-0426
26. Buchowski MS, Schlundt DG, Hargreaves MK, Hankin JH, Signorello LB, Blot WJ (2003) Development of a culturally sensitive food frequency questionnaire for use in the Southern Community Cohort Study. Cell Mol Biol (Noisy-le-grand) 49(8):1295–1304
27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502
28. Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N, Tall AR (2014) ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res 114(1):157–170. doi:10.1161/CIRCRESAHA.114.300738
29. Robinson JG (2010) Low high-density lipoprotein cholesterol and chronic disease risk marker or causal? J Am Coll Cardiol 55(25):2855–2857. doi:10.1016/j.jacc.2010.01.053
30. Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V (2012) Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. J Am Coll Cardiol 60(23):2372–2379. doi:10.1016/j.jacc.2012.09.013
31. Wu MY, Chang TC, Chao TY, Huang MT, Lin HW (2013) Risk of colorectal cancer in chronic kidney disease: a matched cohort study based on administrative data. Ann Surg Oncol 20(12):3885–3891. doi:10.1245/s10434-013-3065-8
32. Jafri H, Alsheikh-Ali AA, Karas RH (2010) Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 55(25):2846–2854. doi:10.1016/j.jacc.2009.12.069
33. Ye X, Fu J, Yang Y, Chen S (2013) Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS ONE 8(2):e57578. doi:10.1371/journal.pone.0057578